Head And Neck Cancer – Pipeline Review, H2 2017

Global Markets Direct’s, ‘Head And Neck Cancer – Pipeline Review, H2 2017’, provides an overview of the Head And Neck Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Head And Neck Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the global therapeutic landscape of Head And Neck Cancer

The report reviews pipeline therapeutics for Head And Neck Cancer by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved Head And Neck Cancer therapeutics and enlists all their major and minor projects

The report assesses Head And Neck Cancer therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news related to pipeline therapeutics for Head And Neck Cancer

Reasons to buy

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Head And Neck Cancer

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Head And Neck Cancer pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

3SBio Inc

4SC AG

AbbVie Inc

Abion Inc

Adaptimmune Therapeutics Plc

Aduro BioTech Inc

Advaxis Inc

Advenchen Laboratories LLC

Affimed GmbH

Altor BioScience Corp

Ambrx Inc

amcure GmbH

Amgen Inc

arGEN-X BV

ArQule Inc

Array BioPharma Inc

Ascentage Pharma Group Corp Ltd

Aspyrian Therapeutics Inc

Astellas Pharma Inc

Astex Pharmaceuticals Inc

AstraZeneca Plc

Atara Biotherapeutics Inc

AVEO Pharmaceuticals Inc

Bayer AG

BeiGene Ltd

Benitec Biopharma Ltd

Bexion Pharmaceuticals LLC

BioDiem Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biomics Biotechnologies Co Ltd

Bionovis SA

BioNTech AG

Biotest AG

Biothera Pharmaceutical Inc

Boehringer Ingelheim GmbH

Boston Biomedical Inc

Bristol-Myers Squibb Co

CBT Pharmaceuticals Inc

CEL-SCI Corp

Celgene Corp

Cell Medica Ltd

Celldex Therapeutics Inc

Cellectar Biosciences Inc

Celprogen Inc

Centrose LLC

Checkpoint Therapeutics Inc

Corvus Pharmaceuticals Inc

Cristal Therapeutics BV

Critical Outcome Technologies Inc

Curevac AG

Cyclacel Pharmaceuticals Inc

CytImmune Sciences Inc

CytomX Therapeutics Inc

Daiichi Sankyo Co Ltd

Denceptor Therapeutics Ltd

DNJ Pharma Inc

Dynavax Technologies Corp

Eisai Co Ltd

Eleven Biotherapeutics Inc

Eli Lilly and Co

Enzene Biosciences Ltd

Etubics Corp

Eureka Therapeutics Inc

F. Hoffmann-La Roche Ltd

Forty Seven Inc

Fujifilm Corp

G&E Herbal Biotechnology Co Ltd

Galectin Therapeutics Inc

Genelux Corp

Genentech Inc

GeneSegues Inc

Genexine Inc

Genmab A/S

GlaxoSmithKline Plc

Glenmark Pharmaceuticals Ltd

Gliknik Inc

Glycotope GmbH

Hanmi Pharmaceuticals Co Ltd

Hookipa Biotech AG

Horizon Pharma Plc

Hutchison MediPharma Ltd

Ignyta Inc

Immatics Biotechnologies GmbH

Immunocore Ltd

Immunomedics Inc

Immunovaccine Inc

Immunovative Therapies Ltd

Incyte Corp

Infinity Pharmaceuticals Inc

Innate Pharma SA

Innovation Pharmaceuticals Inc

Inovio Pharmaceuticals Inc

InteRNA Technologies BV

Iovance Biotherapeutics Inc

IRX Therapeutics Inc

ISA Pharmaceuticals BV

ISU ABXIS Co Ltd

Jiangsu Hengrui Medicine Co Ltd

Jiangsu Kanion Pharmaceutical Co Ltd

Johnson & Johnson

Jounce Therapeutics Inc

Juno Therapeutics Inc

Kite Pharma Inc

Kura Oncology Inc

Laboratoires Pierre Fabre SA

LATITUDE Pharmaceuticals Inc

Loxo Oncology Inc

Lytix Biopharma AS

Mabion SA

MacroGenics Inc

Madrigal Pharmaceuticals Inc.

Marsala Biotech Inc

Mateon Therapeutics Inc

MaxiVAX SA

Meabco A/S

MedImmune LLC

Merck & Co Inc

Merck KGaA

Merrimack Pharmaceuticals Inc

Millennium Pharmaceuticals Inc

Mirati Therapeutics Inc

Moderna Therapeutics Inc

Molecular Templates Inc

Moleculin Biotech Inc

NanoCarrier Co Ltd

NantKwest Inc

Natco Pharma Ltd

NeoImmuneTech Inc

Neonc Technologies Inc

Neumedicines Inc

Northwest Biotherapeutics Inc

Novartis AG

Noxopharm Ltd

Oncobiologics Inc

Oncolys BioPharma Inc

Onconova Therapeutics Inc

OncoSec Medical Inc

Oncovir Inc

Ono Pharmaceutical Co Ltd

Oryx GmbH & Co KG

Otsuka Holdings Co Ltd

PDS Biotechnology Corp

Peregrine Pharmaceuticals Inc

Pfizer Inc

Pharma Mar SA

Plexxikon Inc

PNP Therapeutics Inc

Profectus BioSciences Inc

Provectus Biopharmaceuticals Inc

PsiOxus Therapeutics Ltd

R Pharm

Redx Pharma Plc

Regeneron Pharmaceuticals Inc

Reliance Life Sciences Pvt Ltd

Sareum Holdings Plc

Selecta Biosciences Inc

Shionogi & Co Ltd

Sierra Oncology Inc

Sillajen Biotherapeutics

Sinil Pharmaceutical Co Ltd

Sorrento Therapeutics Inc

Sound Pharmaceuticals Inc

Spherium Biomed SL

Sumitomo Dainippon Pharma Co Ltd

SuviCa Inc

SynCore Biotechnology Co Ltd

Systimmune Inc

Taiwan Liposome Company Ltd

Takara Bio Inc

Takis Srl

Tessa Therapeutics Pte Ltd

Theralase Technologies Inc

Theravectys SA

Tolero Pharmaceuticals Inc

Tosk Inc

Transgene SA

UbiVac LLC

Vaccibody AS

VasGene Therapeutics Inc

Vault Pharma Inc

Vaxeal Holding SA

Vectorite Biomedica Inc

Viracta Therapeutics Inc

Vyriad Inc

Table of Contents

Table of Contents

Table of Contents 2

Introduction 9

Head And Neck Cancer - Overview 10

Head And Neck Cancer - Therapeutics Development 11

Head And Neck Cancer - Therapeutics Assessment 54

Head And Neck Cancer - Companies Involved in Therapeutics Development 79

Head And Neck Cancer - Drug Profiles 166

Head And Neck Cancer - Dormant Projects 1402

Head And Neck Cancer - Discontinued Products 1413

Head And Neck Cancer - Product Development Milestones 1415

Appendix 1428

List of Tables

List of Tables

Number of Products under Development for Head And Neck Cancer, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..3), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..4), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..5), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..6), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..7), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..8), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..9), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..10), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..11), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..12), H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017 (Contd..1), H2 2017

Products under Development by Companies, H2 2017

Products under Development by Companies, H2 2017 (Contd..1), H2 2017

Products under Development by Companies, H2 2017 (Contd..2), H2 2017

Products under Development by Companies, H2 2017 (Contd..3), H2 2017

Products under Development by Companies, H2 2017 (Contd..4), H2 2017

Products under Development by Companies, H2 2017 (Contd..5), H2 2017

Products under Development by Companies, H2 2017 (Contd..6), H2 2017

Products under Development by Companies, H2 2017 (Contd..7), H2 2017

Products under Development by Companies, H2 2017 (Contd..8), H2 2017

Products under Development by Companies, H2 2017 (Contd..9), H2 2017

Products under Development by Companies, H2 2017 (Contd..10), H2 2017

Products under Development by Companies, H2 2017 (Contd..11), H2 2017

Products under Development by Companies, H2 2017 (Contd..12), H2 2017

Products under Development by Companies, H2 2017 (Contd..13), H2 2017

Products under Development by Companies, H2 2017 (Contd..14), H2 2017

Products under Development by Companies, H2 2017 (Contd..15), H2 2017

Products under Development by Companies, H2 2017 (Contd..16), H2 2017

Products under Development by Companies, H2 2017 (Contd..17), H2 2017

Products under Development by Companies, H2 2017 (Contd..18), H2 2017

Products under Development by Companies, H2 2017 (Contd..19), H2 2017

Products under Development by Companies, H2 2017 (Contd..20), H2 2017

Products under Development by Companies, H2 2017 (Contd..21), H2 2017

Products under Development by Universities/Institutes, H2 2017

Products under Development by Universities/Institutes, H2 2017 (Contd..1), H2 2017

Products under Development by Universities/Institutes, H2 2017 (Contd..2), H2 2017

Number of Products by Stage and Target, H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..2), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..3), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..4), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..5), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..6), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..7), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..8), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..2), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..3), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..4), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..5), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..6), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..7), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..8), H2 2017

Number of Products by Stage and Route of Administration, H2 2017

Number of Products by Stage and Molecule Type, H2 2017

Number of Products by Stage and Molecule Type, H2 2017 (Contd..1), H2 2017

Head And Neck Cancer – Pipeline by 3SBio Inc, H2 2017

Head And Neck Cancer – Pipeline by 4SC AG, H2 2017

Head And Neck Cancer – Pipeline by AbbVie Inc, H2 2017

Head And Neck Cancer – Pipeline by Abion Inc, H2 2017

Head And Neck Cancer – Pipeline by Adaptimmune Therapeutics Plc, H2 2017

Head And Neck Cancer – Pipeline by Aduro BioTech Inc, H2 2017

Head And Neck Cancer – Pipeline by Advaxis Inc, H2 2017

Head And Neck Cancer – Pipeline by Advenchen Laboratories LLC, H2 2017

Head And Neck Cancer – Pipeline by Affimed GmbH, H2 2017

Head And Neck Cancer – Pipeline by Altor BioScience Corp, H2 2017

Head And Neck Cancer – Pipeline by Ambrx Inc, H2 2017

Head And Neck Cancer – Pipeline by amcure GmbH, H2 2017

Head And Neck Cancer – Pipeline by Amgen Inc, H2 2017

Head And Neck Cancer – Pipeline by arGEN-X BV, H2 2017

Head And Neck Cancer – Pipeline by ArQule Inc, H2 2017

Head And Neck Cancer – Pipeline by Array BioPharma Inc, H2 2017

Head And Neck Cancer – Pipeline by Ascentage Pharma Group Corp Ltd, H2 2017

Head And Neck Cancer – Pipeline by Aspyrian Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Astellas Pharma Inc, H2 2017

Head And Neck Cancer – Pipeline by Astex Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by AstraZeneca Plc, H2 2017

Head And Neck Cancer – Pipeline by Atara Biotherapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by AVEO Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by Bayer AG, H2 2017

Head And Neck Cancer – Pipeline by BeiGene Ltd, H2 2017

Head And Neck Cancer – Pipeline by Benitec Biopharma Ltd, H2 2017

Head And Neck Cancer – Pipeline by Bexion Pharmaceuticals LLC, H2 2017

Head And Neck Cancer – Pipeline by BioDiem Ltd, H2 2017

Head And Neck Cancer – Pipeline by Biohaven Pharmaceutical Holding Company Ltd, H2 2017

Head And Neck Cancer – Pipeline by Biomics Biotechnologies Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by Bionovis SA, H2 2017

Head And Neck Cancer – Pipeline by BioNTech AG, H2 2017

Head And Neck Cancer – Pipeline by Biotest AG, H2 2017

Head And Neck Cancer – Pipeline by Biothera Pharmaceutical Inc, H2 2017

Head And Neck Cancer – Pipeline by Boehringer Ingelheim GmbH, H2 2017

Head And Neck Cancer – Pipeline by Boston Biomedical Inc, H2 2017

Head And Neck Cancer – Pipeline by Bristol-Myers Squibb Co, H2 2017

Head And Neck Cancer – Pipeline by CBT Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by CEL-SCI Corp, H2 2017

Head And Neck Cancer – Pipeline by Celgene Corp, H2 2017

Head And Neck Cancer – Pipeline by Cell Medica Ltd, H2 2017

Head And Neck Cancer – Pipeline by Celldex Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Cellectar Biosciences Inc, H2 2017

Head And Neck Cancer – Pipeline by Celprogen Inc, H2 2017

Head And Neck Cancer – Pipeline by Centrose LLC, H2 2017

Head And Neck Cancer – Pipeline by Checkpoint Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Corvus Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by Cristal Therapeutics BV, H2 2017

Head And Neck Cancer – Pipeline by Critical Outcome Technologies Inc, H2 2017

Head And Neck Cancer – Pipeline by Curevac AG, H2 2017

Head And Neck Cancer – Pipeline by Cyclacel Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by CytImmune Sciences Inc, H2 2017

Head And Neck Cancer – Pipeline by CytomX Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Daiichi Sankyo Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by Denceptor Therapeutics Ltd, H2 2017

Head And Neck Cancer – Pipeline by DNJ Pharma Inc, H2 2017

Head And Neck Cancer – Pipeline by Dynavax Technologies Corp, H2 2017

Head And Neck Cancer – Pipeline by Eisai Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by Eleven Biotherapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Eli Lilly and Co, H2 2017

Head And Neck Cancer – Pipeline by Enzene Biosciences Ltd, H2 2017

Head And Neck Cancer – Pipeline by Etubics Corp, H2 2017

Head And Neck Cancer – Pipeline by Eureka Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by F. Hoffmann-La Roche Ltd, H2 2017

Head And Neck Cancer – Pipeline by Forty Seven Inc, H2 2017

Head And Neck Cancer – Pipeline by Fujifilm Corp, H2 2017

Head And Neck Cancer – Pipeline by G&E Herbal Biotechnology Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by Galectin Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Genelux Corp, H2 2017

Head And Neck Cancer – Pipeline by Genentech Inc, H2 2017

Head And Neck Cancer – Pipeline by GeneSegues Inc, H2 2017

Head And Neck Cancer – Pipeline by Genexine Inc, H2 2017

Head And Neck Cancer – Pipeline by Genmab A/S, H2 2017

Head And Neck Cancer – Pipeline by GlaxoSmithKline Plc, H2 2017

Head And Neck Cancer – Pipeline by Glenmark Pharmaceuticals Ltd, H2 2017

Head And Neck Cancer – Pipeline by Gliknik Inc, H2 2017

Head And Neck Cancer – Pipeline by Glycotope GmbH, H2 2017

Head And Neck Cancer – Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by Hookipa Biotech AG, H2 2017

Head And Neck Cancer – Pipeline by Horizon Pharma Plc, H2 2017

Head And Neck Cancer – Pipeline by Hutchison MediPharma Ltd, H2 2017

Head And Neck Cancer – Pipeline by Ignyta Inc, H2 2017

Head And Neck Cancer – Pipeline by Immatics Biotechnologies GmbH, H2 2017

Head And Neck Cancer – Pipeline by Immunocore Ltd, H2 2017

Head And Neck Cancer – Pipeline by Immunomedics Inc, H2 2017

Head And Neck Cancer – Pipeline by Immunovaccine Inc, H2 2017

Head And Neck Cancer – Pipeline by Immunovative Therapies Ltd, H2 2017

Head And Neck Cancer – Pipeline by Incyte Corp, H2 2017

Head And Neck Cancer – Pipeline by Infinity Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by Innate Pharma SA, H2 2017

Head And Neck Cancer – Pipeline by Innovation Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by Inovio Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by InteRNA Technologies BV, H2 2017

Head And Neck Cancer – Pipeline by Iovance Biotherapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by IRX Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by ISA Pharmaceuticals BV, H2 2017

Head And Neck Cancer – Pipeline by ISU ABXIS Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by Johnson & Johnson, H2 2017

Head And Neck Cancer – Pipeline by Jounce Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Juno Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Kite Pharma Inc, H2 2017

Head And Neck Cancer – Pipeline by Kura Oncology Inc, H2 2017

Head And Neck Cancer – Pipeline by Laboratoires Pierre Fabre SA, H2 2017

Head And Neck Cancer – Pipeline by LATITUDE Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by Loxo Oncology Inc, H2 2017

Head And Neck Cancer – Pipeline by Lytix Biopharma AS, H2 2017

Head And Neck Cancer – Pipeline by Mabion SA, H2 2017

Head And Neck Cancer – Pipeline by MacroGenics Inc, H2 2017

Head And Neck Cancer – Pipeline by Madrigal Pharmaceuticals Inc., H2 2017

Head And Neck Cancer – Pipeline by Marsala Biotech Inc, H2 2017

Head And Neck Cancer – Pipeline by Mateon Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by MaxiVAX SA, H2 2017

Head And Neck Cancer – Pipeline by Meabco A/S, H2 2017

Head And Neck Cancer – Pipeline by MedImmune LLC, H2 2017

Head And Neck Cancer – Pipeline by Merck & Co Inc, H2 2017

Head And Neck Cancer – Pipeline by Merck KGaA, H2 2017

Head And Neck Cancer – Pipeline by Merrimack Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by Millennium Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by Mirati Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Moderna Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Molecular Templates Inc, H2 2017

Head And Neck Cancer – Pipeline by Moleculin Biotech Inc, H2 2017

Head And Neck Cancer – Pipeline by NanoCarrier Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by NantKwest Inc, H2 2017

Head And Neck Cancer – Pipeline by Natco Pharma Ltd, H2 2017

Head And Neck Cancer – Pipeline by NeoImmuneTech Inc, H2 2017

Head And Neck Cancer – Pipeline by Neonc Technologies Inc, H2 2017

Head And Neck Cancer – Pipeline by Neumedicines Inc, H2 2017

Head And Neck Cancer – Pipeline by Northwest Biotherapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Novartis AG, H2 2017

Head And Neck Cancer – Pipeline by Noxopharm Ltd, H2 2017

Head And Neck Cancer – Pipeline by Oncobiologics Inc, H2 2017

Head And Neck Cancer – Pipeline by Oncolys BioPharma Inc, H2 2017

Head And Neck Cancer – Pipeline by Onconova Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by OncoSec Medical Inc, H2 2017

Head And Neck Cancer – Pipeline by Oncovir Inc, H2 2017

Head And Neck Cancer – Pipeline by Ono Pharmaceutical Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by Oryx GmbH & Co KG, H2 2017

Head And Neck Cancer – Pipeline by Otsuka Holdings Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by PDS Biotechnology Corp, H2 2017

Head And Neck Cancer – Pipeline by Peregrine Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by Pfizer Inc, H2 2017

Head And Neck Cancer – Pipeline by Pharma Mar SA, H2 2017

Head And Neck Cancer – Pipeline by Plexxikon Inc, H2 2017

Head And Neck Cancer – Pipeline by PNP Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Profectus BioSciences Inc, H2 2017

Head And Neck Cancer – Pipeline by Provectus Biopharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by PsiOxus Therapeutics Ltd, H2 2017

Head And Neck Cancer – Pipeline by R Pharm, H2 2017

Head And Neck Cancer – Pipeline by Redx Pharma Plc, H2 2017

Head And Neck Cancer – Pipeline by Regeneron Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by Reliance Life Sciences Pvt Ltd, H2 2017

Head And Neck Cancer – Pipeline by Sareum Holdings Plc, H2 2017

Head And Neck Cancer – Pipeline by Selecta Biosciences Inc, H2 2017

Head And Neck Cancer – Pipeline by Shionogi & Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by Sierra Oncology Inc, H2 2017

Head And Neck Cancer – Pipeline by Sillajen Biotherapeutics, H2 2017

Head And Neck Cancer – Pipeline by Sinil Pharmaceutical Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by Sorrento Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Sound Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by Spherium Biomed SL, H2 2017

Head And Neck Cancer – Pipeline by Sumitomo Dainippon Pharma Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by SuviCa Inc, H2 2017

Head And Neck Cancer – Pipeline by SynCore Biotechnology Co Ltd, H2 2017

Head And Neck Cancer – Pipeline by Systimmune Inc, H2 2017

Head And Neck Cancer – Pipeline by Taiwan Liposome Company Ltd, H2 2017

Head And Neck Cancer – Pipeline by Takara Bio Inc, H2 2017

Head And Neck Cancer – Pipeline by Takis Srl, H2 2017

Head And Neck Cancer – Pipeline by Tessa Therapeutics Pte Ltd, H2 2017

Head And Neck Cancer – Pipeline by Theralase Technologies Inc, H2 2017

Head And Neck Cancer – Pipeline by Theravectys SA, H2 2017

Head And Neck Cancer – Pipeline by Tolero Pharmaceuticals Inc, H2 2017

Head And Neck Cancer – Pipeline by Tosk Inc, H2 2017

Head And Neck Cancer – Pipeline by Transgene SA, H2 2017

Head And Neck Cancer – Pipeline by UbiVac LLC, H2 2017

Head And Neck Cancer – Pipeline by Vaccibody AS, H2 2017

Head And Neck Cancer – Pipeline by VasGene Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Vault Pharma Inc, H2 2017

Head And Neck Cancer – Pipeline by Vaxeal Holding SA, H2 2017

Head And Neck Cancer – Pipeline by Vectorite Biomedica Inc, H2 2017

Head And Neck Cancer – Pipeline by Viracta Therapeutics Inc, H2 2017

Head And Neck Cancer – Pipeline by Vyriad Inc, H2 2017

Head And Neck Cancer – Dormant Projects, H2 2017

Head And Neck Cancer – Dormant Projects, H2 2017 (Contd..1), H2 2017

Head And Neck Cancer – Dormant Projects, H2 2017 (Contd..2), H2 2017

Head And Neck Cancer – Dormant Projects, H2 2017 (Contd..3), H2 2017

Head And Neck Cancer – Dormant Projects, H2 2017 (Contd..4), H2 2017

Head And Neck Cancer – Dormant Projects, H2 2017 (Contd..5), H2 2017

Head And Neck Cancer – Dormant Projects, H2 2017 (Contd..6), H2 2017

Head And Neck Cancer – Dormant Projects, H2 2017 (Contd..7), H2 2017

Head And Neck Cancer – Dormant Projects, H2 2017 (Contd..8), H2 2017

Head And Neck Cancer – Dormant Projects, H2 2017 (Contd..9), H2 2017

Head And Neck Cancer – Dormant Projects, H2 2017 (Contd..10), H2 2017

Head And Neck Cancer – Discontinued Products, H2 2017

Head And Neck Cancer – Discontinued Products, H2 2017 (Contd..1), H2 2017

List of Figures

List of Figures

Number of Products under Development for Head And Neck Cancer, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Number of Products by Top 10 Targets, H2 2017

Number of Products by Stage and Top 10 Targets, H2 2017

Number of Products by Top 10 Mechanism of Actions, H2 2017

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017

Number of Products by Top 10 Routes of Administration, H2 2017

Number of Products by Stage and Top 10 Routes of Administration, H2 2017

Number of Products by Top 10 Molecule Types, H2 2017

Number of Products by Stage and Top 10 Molecule Types, H2 2017

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports